Enwei Pharmaceutical Revenue

Enwei Pharmaceutical had revenue of 187.63M CNY in the quarter ending September 30, 2025, with 8.97% growth. This brings the company's revenue in the last twelve months to 888.64M, up 14.57% year-over-year. In the year 2024, Enwei Pharmaceutical had annual revenue of 812.13M with 3.43% growth.

Revenue (ttm)

888.64M

Revenue Growth

+14.57%

P/S Ratio

3.32

Revenue / Employee

574.06K

Employees

1,548

Market Cap

2.95B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.13M	26.94M	3.43%
Dec 31, 2023	785.19M	93.62M	13.54%
Jan 1, 2023	691.57M	11.88M	1.75%
Jan 1, 2022	679.70M	45.54M	7.18%
Dec 31, 2020	634.16M	13.49M	2.17%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Anhui Fengyuan Pharmaceutical	4.15B
Guizhou Yibai Pharmaceutical	1.91B
Hainan Huluwa Pharmaceutical Group	1.06B
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	914.65M
ShanXi C&Y Pharmaceutical Group Co.,LTD.	849.26M
Ginwa Enterprise (Group)	550.44M
Zhejiang Shapuaisi Pharmaceutical	475.19M
Lionco Pharmaceutical Group	430.61M

Revenue Rankings